Antisense DNAs as multisite genomic modulators identified by DNA microarray

Yee Sook Cho, Meyoung-Kon Kim, Chris Cheadle, Catherine Neary, Kevin G. Becker, Yoon S. Cho-Chung

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

Antisense oligodeoxynucleotides can selectively block disease-causing genes, and cancer genes have been chosen as potential targets for antisense drugs to treat cancer. However, nonspecific side effects have clouded the true antisense mechanism of action and hampered clinical development of antisense therapeutics. Using DNA microarrays, we have conducted a systematic characterization of gene expression in cells exposed to antisense, either exogenously or endogenously. Here, we show that in a sequence-specific manner, antisense targeted to protein kinase A RIα alters expression of the clusters of coordinately expressed genes at a specific stage of cell growth, differentiation, and activation. The genes that define the proliferation-transformation signature are down-regulated, whereas those that define the differentiation-reverse transformation signature are up-regulated in antisense-treated cancer cells and tumors, but not in host livers. In this differentiation signature, the genes showing the highest induction include genes for the G proteins Rap1 and Cdc42. The expression signature induced by the exogenously supplied antisense oligodeoxynucleotide overlaps strikingly with that induced by endogenous antisense gene overexpression. Defining antisense DNAs on the basis of their effects on global gene expression can lead to identification of clinically relevant antisense therapeutics and can identify which molecular and cellular events might be important in complex biological processes, such as cell growth and differentiation.

Original languageEnglish
Pages (from-to)9819-9823
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume98
Issue number17
DOIs
Publication statusPublished - 2001 Aug 14
Externally publishedYes

Fingerprint

Antisense DNA
Oligonucleotide Array Sequence Analysis
Oligodeoxyribonucleotides
Genes
Cell Differentiation
Biological Phenomena
Gene Expression
Neoplasms
Neoplasm Genes
Growth
Cyclic AMP-Dependent Protein Kinases
GTP-Binding Proteins
Liver
Therapeutics
Pharmaceutical Preparations
Proteins

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

Antisense DNAs as multisite genomic modulators identified by DNA microarray. / Cho, Yee Sook; Kim, Meyoung-Kon; Cheadle, Chris; Neary, Catherine; Becker, Kevin G.; Cho-Chung, Yoon S.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 98, No. 17, 14.08.2001, p. 9819-9823.

Research output: Contribution to journalArticle

Cho, Yee Sook ; Kim, Meyoung-Kon ; Cheadle, Chris ; Neary, Catherine ; Becker, Kevin G. ; Cho-Chung, Yoon S. / Antisense DNAs as multisite genomic modulators identified by DNA microarray. In: Proceedings of the National Academy of Sciences of the United States of America. 2001 ; Vol. 98, No. 17. pp. 9819-9823.
@article{e5088c04dbf348af80af506a092f6920,
title = "Antisense DNAs as multisite genomic modulators identified by DNA microarray",
abstract = "Antisense oligodeoxynucleotides can selectively block disease-causing genes, and cancer genes have been chosen as potential targets for antisense drugs to treat cancer. However, nonspecific side effects have clouded the true antisense mechanism of action and hampered clinical development of antisense therapeutics. Using DNA microarrays, we have conducted a systematic characterization of gene expression in cells exposed to antisense, either exogenously or endogenously. Here, we show that in a sequence-specific manner, antisense targeted to protein kinase A RIα alters expression of the clusters of coordinately expressed genes at a specific stage of cell growth, differentiation, and activation. The genes that define the proliferation-transformation signature are down-regulated, whereas those that define the differentiation-reverse transformation signature are up-regulated in antisense-treated cancer cells and tumors, but not in host livers. In this differentiation signature, the genes showing the highest induction include genes for the G proteins Rap1 and Cdc42. The expression signature induced by the exogenously supplied antisense oligodeoxynucleotide overlaps strikingly with that induced by endogenous antisense gene overexpression. Defining antisense DNAs on the basis of their effects on global gene expression can lead to identification of clinically relevant antisense therapeutics and can identify which molecular and cellular events might be important in complex biological processes, such as cell growth and differentiation.",
author = "Cho, {Yee Sook} and Meyoung-Kon Kim and Chris Cheadle and Catherine Neary and Becker, {Kevin G.} and Cho-Chung, {Yoon S.}",
year = "2001",
month = "8",
day = "14",
doi = "10.1073/pnas.171314398",
language = "English",
volume = "98",
pages = "9819--9823",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "17",

}

TY - JOUR

T1 - Antisense DNAs as multisite genomic modulators identified by DNA microarray

AU - Cho, Yee Sook

AU - Kim, Meyoung-Kon

AU - Cheadle, Chris

AU - Neary, Catherine

AU - Becker, Kevin G.

AU - Cho-Chung, Yoon S.

PY - 2001/8/14

Y1 - 2001/8/14

N2 - Antisense oligodeoxynucleotides can selectively block disease-causing genes, and cancer genes have been chosen as potential targets for antisense drugs to treat cancer. However, nonspecific side effects have clouded the true antisense mechanism of action and hampered clinical development of antisense therapeutics. Using DNA microarrays, we have conducted a systematic characterization of gene expression in cells exposed to antisense, either exogenously or endogenously. Here, we show that in a sequence-specific manner, antisense targeted to protein kinase A RIα alters expression of the clusters of coordinately expressed genes at a specific stage of cell growth, differentiation, and activation. The genes that define the proliferation-transformation signature are down-regulated, whereas those that define the differentiation-reverse transformation signature are up-regulated in antisense-treated cancer cells and tumors, but not in host livers. In this differentiation signature, the genes showing the highest induction include genes for the G proteins Rap1 and Cdc42. The expression signature induced by the exogenously supplied antisense oligodeoxynucleotide overlaps strikingly with that induced by endogenous antisense gene overexpression. Defining antisense DNAs on the basis of their effects on global gene expression can lead to identification of clinically relevant antisense therapeutics and can identify which molecular and cellular events might be important in complex biological processes, such as cell growth and differentiation.

AB - Antisense oligodeoxynucleotides can selectively block disease-causing genes, and cancer genes have been chosen as potential targets for antisense drugs to treat cancer. However, nonspecific side effects have clouded the true antisense mechanism of action and hampered clinical development of antisense therapeutics. Using DNA microarrays, we have conducted a systematic characterization of gene expression in cells exposed to antisense, either exogenously or endogenously. Here, we show that in a sequence-specific manner, antisense targeted to protein kinase A RIα alters expression of the clusters of coordinately expressed genes at a specific stage of cell growth, differentiation, and activation. The genes that define the proliferation-transformation signature are down-regulated, whereas those that define the differentiation-reverse transformation signature are up-regulated in antisense-treated cancer cells and tumors, but not in host livers. In this differentiation signature, the genes showing the highest induction include genes for the G proteins Rap1 and Cdc42. The expression signature induced by the exogenously supplied antisense oligodeoxynucleotide overlaps strikingly with that induced by endogenous antisense gene overexpression. Defining antisense DNAs on the basis of their effects on global gene expression can lead to identification of clinically relevant antisense therapeutics and can identify which molecular and cellular events might be important in complex biological processes, such as cell growth and differentiation.

UR - http://www.scopus.com/inward/record.url?scp=0035859872&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035859872&partnerID=8YFLogxK

U2 - 10.1073/pnas.171314398

DO - 10.1073/pnas.171314398

M3 - Article

VL - 98

SP - 9819

EP - 9823

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 17

ER -